Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy is a leading provider of outpatient physical and occupational therapy services, with a diverse range of services and a strong mix of payment sources. The company is focused on both expanding its reach through strategic partnerships and acquisitions, as well as maintaining strong financial discipline. The recent weather challenges and loss of patient visits in Q1 appear to have been temporary setbacks and the company's strong patient revenue, growth in industrial injury prevention business, and focus on cost management provide a positive outlook for future profitability and growth potential.

Bears say

US Physical Therapy is facing multiple challenges that could negatively impact its profitability, with potential wage pressure for clinicians, reimbursement pressure from Medicare, and the potential for economic contraction. Despite a strong revenue growth outlook for the next few years, these factors could limit the company's potential earnings capabilities and negatively impact its expansion plans, including its partnerships with hospital systems. Additionally, the company's reliance on Medicare as a key source of revenue could also be a concern for investors.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $99.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $99.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.